K.J. Harrison & Partners Inc Invests $851,000 in Corteva, Inc. $CTVA

K.J. Harrison & Partners Inc bought a new stake in shares of Corteva, Inc. (NYSE:CTVA) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 10,050 shares of the company’s stock, valued at approximately $851,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. JPL Wealth Management LLC bought a new stake in Corteva during the third quarter worth approximately $25,000. Garton & Associates Financial Advisors LLC bought a new stake in shares of Corteva in the 4th quarter valued at approximately $27,000. Bank of Jackson Hole Trust purchased a new position in shares of Corteva in the 4th quarter worth approximately $28,000. Cornerstone Financial Management LLC purchased a new position in shares of Corteva in the 4th quarter worth approximately $29,000. Finally, Elevation Wealth Partners LLC increased its position in shares of Corteva by 334.6% during the 2nd quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock valued at $29,000 after purchasing an additional 261 shares during the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Stock Performance

Shares of Corteva stock opened at $75.73 on Tuesday. The stock’s fifty day moving average is $81.78 and its two-hundred day moving average is $80.09. The company has a market capitalization of $50.53 billion, a PE ratio of 50.15, a price-to-earnings-growth ratio of 2.35 and a beta of 0.57. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $90.97.

Corteva (NYSE:CTVA) last issued its earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.24 by $0.06. The firm had revenue of $6.38 billion during the quarter, compared to analyst estimates of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The business’s revenue was down 1.2% on a year-over-year basis. During the same period in the previous year, the firm earned $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be given a dividend of $0.18 per share. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.0%. Corteva’s dividend payout ratio (DPR) is 47.68%.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. JPMorgan Chase & Co. raised their price target on Corteva from $77.00 to $83.00 and gave the stock a “neutral” rating in a research report on Monday, August 3rd. BNP Paribas Exane boosted their price objective on shares of Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. Jefferies Financial Group increased their target price on shares of Corteva from $95.00 to $97.00 in a research note on Thursday, May 7th. Royal Bank Of Canada raised their target price on shares of Corteva from $97.00 to $103.00 and gave the stock an “outperform” rating in a report on Tuesday, July 21st. Finally, Mizuho lifted their price target on shares of Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a research note on Tuesday, July 14th. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $91.70.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.